Stamaril Injection
Yellow fever Virus (Live attenuated) Vaccine
1000u/0.5ml
Sanofi Pasteur S A ,France
| Pack size | 1's pack |
|---|---|
| Unite Price | 2257.00 BDT |
Indications
Stamaril Injection is used for:
Prophylaxis of Yellow fever infection
Adult Dose
Subcutaneous
Active immunisation against yellow fever
Adult: Primary Vaccination: 0.5 ml, given as SC inj (preferably into the deltoid area) as a single dose, at least 10 days prior to travel.
Booster dose: Repeat dose every 10 yr for those at continued risk of exposure.
Child Dose
Child: >9 mth: 0.5 ml, given as SC inj (preferably into the deltoid area for children >3 yr and thigh area for children <3 yr), at least 10 days prior to travel.
For booster dose: Repeat dose every 10 yr for those at continued risk of exposure.
Renal Dose
Administration
Contra Indications
Hypersensitivity reaction to eggs, chicken proteins or to any component of this vaccine.
Serious hypersensitivity reactions (eg, anaphylaxis) after a previous dose of any yellow fever vaccine.
Immunosuppression, whether congenital, idiopathic or as a result of treatment with systemic steroids (greater than the standard dose of topical or inhaled steroids), radiotherapy or cytotoxic drugs.
History of thymus dysfunction (including thymoma, thymectomy).
Symptomatic HIV infection.
Asymptomatic HIV infection when accompanied by evidence of impaired immune function (see Precautions).
Age <6 months (see Dosage & Administration and Precautions).
Current severe febrile illness.
Precautions
Caution when used in immunocompromised patients e.g. patients receiving chemo/radiation therapy or other immunosuppressive therapy such as high-dose corticosteroids and patients <24 mth after haematopoietic stem cell transplant. Elderly; increased risk of adverse effects when used in patients ≥65 yr. Monitor for adverse events 10-30 days post-vaccination. Pregnancy.
Lactation: There is a theoretical risk of transmission of vaccine components to the infants from breast-feeding mothers, lactation constitutes a contraindication, particularly when infants are <9 months of age because of the risk of encephalitis
Pregnancy-Lactation
Pregnancy Category: C
Lactation: There is a theoretical risk of transmission of vaccine components to the infants from breast-feeding mothers, lactation constitutes a contraindication, particularly when infants are <9 months of age because of the risk of encephalitis
Interactions
Immunosuppressants eg cytotoxic agents, systemic steroids.
Side Effects
Side effects of Yellow fever Virus (Live attenuated) Vaccine :
1-10%
Headache (5-10%), Chills (5-10%), Low-grade fever (5-10%), Myalgia (5-10%)
Frequency Not Defined
Meningoencephalitis, Seizures, Rash, Urticaria, Pain, Warmth, Erythema, Guillain-Barre syndrome
Mode of Action
Live, attenuated virus stimulates active immunity to Yellow fever; conveys active immunity via stimulation of production of endogenously produced antibodies.
Note
Stamaril 1000u/0.5ml Injection generic name is Yellow fever Virus (Live attenuated) Vaccine. Stamaril 1000u/0.5ml Injection is manufactured by Sanofi Pasteur S A ,FranceStamaril is availble in all over Bangladesh.
Mes BD drug index information on Stamaril Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.